Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23

Showing 23 citing articles:

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
Alessio Rizzo, Manuela Racca, Sara Dall’Armellina, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 564-564
Open Access | Times Cited: 21
Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib
Chun‐Han Hou, Wei‐Li Chen, Chih‐Yang Lin
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 4
Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study
Jie Liu, Wei-Liang Gao, Xiong Zheng, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
M. Ambrose, Jin-Hyung Lee, Aleem Syed, et al.
Frontiers in Drug Discovery (2025) Vol. 5
Open Access
Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancer
P. F. Benson, Omar Abdel‐Rahman
Immunotherapy (2025), pp. 1-9
Closed Access
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
Jingjing Chai, Jiaqi Lv, Jian Xiong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Correlation analysis between BRAFV600E mutation and ultrasonic and clinical features of papillary thyroid cancer
Jiahao Wen, Haizhou Liu, Yanyan Lin, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29955-e29955
Open Access | Times Cited: 2
Thyroid Nodules: Past, Present, and Future
Alan A. Parsa, Hossein Gharib
Endocrine Practice (2024)
Closed Access | Times Cited: 2
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6734-6734
Open Access | Times Cited: 2
Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer
Saied Mirshahidi, Isabella J. Yuan, Alfred Simental, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5471-5471
Open Access | Times Cited: 4
Lenvatinib-Loaded Poly(lactic-co-glycolic acid) Nanoparticles with Epidermal Growth Factor Receptor Antibody Conjugation as a Preclinical Approach to Therapeutically Improve Thyroid Cancer with Aggressive Behavior
Giovanna Revilla, Nuseibah Al Qtaish, Pablo Caruana, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1647-1647
Open Access | Times Cited: 4
Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer
Zongfu Pan, Xixuan Lu, Tong Xu, et al.
Cancer Letters (2023) Vol. 580, pp. 216496-216496
Closed Access | Times Cited: 4
Imaging through PSMA-targeted PET in patients diagnosed with radioiodine-refractory thyroid cancer, a flash in the pan or a game changer?
Alessio Rizzo, Arnoldo Piccardo, Giorgio Treglia
Endocrine (2024) Vol. 85, Iss. 2, pp. 601-603
Closed Access | Times Cited: 1
Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies
Ilona Kaczmarzyk, Martyna Nowak-Perlak, Marta Woźniak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4463-4463
Open Access | Times Cited: 1
Survival in Thyroid Cancer in Sweden From 1999 To 2018
Frantisek Zitricky, Anni Koskinen, Kristina Sundquist, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 659-671
Open Access | Times Cited: 1
Early mortality critically impedes improvements in thyroid cancer survival through a half century
Filip Tichánek, Asta Försti, Vaclv Liska, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 3, pp. 355-362
Closed Access | Times Cited: 2
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma
Daniela Weiler, María del Sol Pérez Lago
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 11, pp. 3467-3468
Closed Access
Clinicopathological study of thyroid gland cancer among selected sample Basrah province between 2019-2022
Oula Fouad Hameed, Zainab Abdulkareem Maktoof, Muntaha Awad ALdeewan
Romanian Journal of Medical Practice (2024) Vol. 19, Iss. 2, pp. 169-172
Open Access
Aggressive Types of Malignant Thyroid Neoplasms
Maria Boudina, Eleana Zisimopoulou, Persefoni Xirou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6119-6119
Open Access
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth
Mateo N. Campos Haedo, Johanna Abigail Díaz Albuja, Sandra Camarero‐Espinosa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12158-12158
Open Access
Progress in the Study of Gene Mutations Associated with Papillary Thyroid Carcinoma
Jingjie Luo, Xin Dai, Xinyi Ren, et al.
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 11, pp. 334-347
Open Access
Dabrafenib Inhibits Egr‐1‐Mediated Adhesion of Thyroid Cancer Cells to Pulmonary Microvascular Endothelium
Yanchao Qin, Wei Ding, Xuesong Wu, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access
Association of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Clinicopathological Features and Short-Term Outcome in Well-Differentiated Thyroid Cancer
Sumeet Suresh Malapure, Sibi Oommen, Shivanand Bhushan, et al.
Indian Journal of Nuclear Medicine (2023) Vol. 38, Iss. 4, pp. 313-319
Open Access | Times Cited: 1
Page 1

Scroll to top